Drp1^SD overexpression in <i>opa1</i> RNAi and <i>marf</i> RNAi expressing type II NB lineages suppresses the differentiation defect. by Dnyanesh Dubal (12085942)

A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele-0 by Ryan J Haasl (92283)

“…<p><b>Copyright information:</b></p><p>Taken from "A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele"</p><p>http://www.biomedcentral.com/1471-2350/9/37</p><p>BMC Medical Genetics 2008;9():37-37.…”

A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele-1 by Ryan J Haasl (92283)

“…<p><b>Copyright information:</b></p><p>Taken from "A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele"</p><p>http://www.biomedcentral.com/1471-2350/9/37</p><p>BMC Medical Genetics 2008;9():37-37.…”

Subcellular levels of p53 protein in hTCEpi-TR cell lines. by Vindhya Koppaka (845151)

Tethering transiently decreases the singing rate. by Homare Yamahachi (363988)

CpG/c stimulated CLL B cells exhibit decreased survival and decreased activation of the Wnt pathway. by Albert Gutierrez Jr. (342562)

PD 98059 decreases the phosphorylation of ERK in HSVEC, but does not restore ATP-induced decrease in endothelial function in RA. by Padmini Komalavilas (402160)

Kcnk5b enhanced depolarization is required for enhanced fin bud growth. by Xiaowen Jiang (8291814)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Effect of ex vivo treatment with rhTGFβ1 or a TGFβ1 inhibitor on monocyte responses to rgE stimulation.... by Michael J. Johnson (5818168)

“…<p>Effect of ex vivo treatment with rhTGFβ1 or a TGFβ1 inhibitor on monocyte responses to rgE stimulation. …”

Norepinephrine clearance is decreased in the hypoperfused kidney. by Rong Gu (231159)

Maternal exposure to U-46619 decreases fetal body weight at E19 compared to sham pups. by Camille M. Fung (844334)

“…Body weights of exposed fetuses remained similar to shams at E15.5 and E17.5, but were statistically decreased by E19 (p < 0.001: e15.5 Sham n = 13, e15.5 TXA n = 21, e17.5 Sham n = 8, e17.5 TXA n = 11, e19 Sham n = 5, e19 TXA n = 5).…”

Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia. by Qinyu Luo (13000956)

The Samn-Perelli Scale is a 7-point Likert scale used to assess fatigue [42, 45]. by Marcel F. Hinss (14675457)

Hyperlipidemia-Associated Renal Damage Decreases Klotho Expression in Kidneys from ApoE Knockout Mice by Cristina Sastre (503532)

“…</p><p>Methods</p><p>We evaluated whether hyperlipidemia modulates Klotho expression in kidneys from C57BL/6 and hyperlipidemic apolipoprotein E knockout (ApoE KO) mice fed with a normal chow diet (ND) or a Western-type high cholesterol-fat diet (HC) for 5 to 10 weeks, respectively.…”

Bile acid changes observed on D7 and 14 post-weaning in response to feeding a control diet or a diet containing MCOA. by Natalie E. Diether (16705804)

Prolonged transforming growth factor (TGF)-βtreatment induced a decrease in total Smad2 and/or Smad3 in many cell strains by Kimberly A Brown (26546)

Conditional stabilization of β-catenin decreases frequency of Tbr2-expressing cells. by Christopher A. Mutch (243132)

“…<p>Coronal sections of E14.5 control and β-catenin ΔEx3 cortices were stained with the intermediate progenitor marker Tbr2 and DAPI. …”

Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia. by Qinyu Luo (13000956)

Decreased Expression of Hypermethylated “Common Target” Genes Predict for Poor Clinical Prognosis by Timothy A Chan (49811)

“…<i>p</i>-Values from representative analyses for specific genes are shown. Blue indicates that a decrease in expression of the indicated gene is significantly associated with the following: overall survival or disease-specific survival less than 5 y, metastasis versus primary tumor, and/or increased grade or invasiveness. …”